Որոնման արդյունքները - Mahvish Muzaffar

  • Ցուցադրվում են 1 - 13 արդյունքները 13
Հստակեցնել արդյունքները
  1. 1
    The Mechanism of Enhanced Insulin Amyloid Fibril Formation by NaCl Is Better Explained by a Conformational Change Model

    The Mechanism of Enhanced Insulin Amyloid Fibril Formation by NaCl Is Better Explained by a Conformational Change Model ‌ Mahvish Muzaffar, Atta Ahmad

    Հրապարակվել է 2011
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  2. 2
    Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

    Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer ‌ Shravanti Macherla, Shachar Laks, Abdul Rafeh Naqash, Anushi Bulumulle, Emmanuel E. Zervos, Mahvish Muzaffar

    Հրապարակվել է 2018
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Revisão
    Պահել ցուցակում
    Պահպանված է:
  3. 3
    Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study

    Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (K... ‌ Benoît You, Christopher Purdy, Larry J. Copeland, Elizabeth M. Swisher, Michael A. Bookman, Gini F. Fleming, Robert L. Coleman, Leslie M. Randall, Krishnansu S. Tewari, Bradley J. Monk, Robert S. Mannel, Joan L. Walker, Fabio Cappuccini, David E. Cohn, Mahvish Muzaffar, David G. Mutch, Andrea E. Wahner Hendrickson, Lainie P. Martin, Olivier Colomban, Robert A. Burger

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  4. 4
    Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade

    Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade ‌ David J. Pinato, Takahiro Kaneko, Anwaar Saeed, Tiziana Pressiani, Ahmed O. Kaseb, Yinghong Wang, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Chieh-Ju Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Abugabal, Celina Ang, Thomas U. Marron, Uqba Khan, Nicola Personeni, Lorenza Rimassa, Yi‐Hsiang Huang

    Հրապարակվել է 2020
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  5. 5
    Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

    Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study ‌ Petros Fessas, Ahmed O. Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Khan, Chieh-Ju Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Francesca Benevento, Hannah Hildebrand, Tiziana Pressiani, Yehia I. Abugabal, Nicola Personeni, Yi‐Hsiang Huang, Lorenza Rimassa, Celina Ang, Thomas U. Marron, David J. Pinato

    Հրապարակվել է 2020
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  6. 6
    Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study

    Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched s... ‌ Brett Marinelli, Edward Kim, Antonio D’Alessio, Mario A. Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O. Kaseb, Yehia I. Abugabal, Anjana Pillai, Yi‐Hsiang Huang, Uqba Khan, Mahvish Muzaffar, Abdul Rafeh Naqash, Rahul Patel, A. Fischman, V. Bishay, Dominik Bettinger, Max W. Sung, Celina Ang, Myron Schwartz, David J. Pinato, Thomas U. Marron

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  7. 7
    Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer

    Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune c... ‌ Abdul Rafeh Naqash, Justin McCallen, Emma Mi, Sanna Iivanainen, Mona A. Marie, Daria Gramenitskaya, James J. Clark, Jussi Koivunen, Shravanti Macherla, Sweta Jonnalagadda, Shanker Polsani, Rahim Jiwani, Maida Hafiz, Mahvish Muzaffar, Leonardo Brunetti, Chipman Robert Geoffrey Stroud, Paul R. Walker, Kun Wang, Youngmin Chung, Eytan Ruppin, Se‐Hoon Lee, Li V. Yang, David J. Pinato, Joo Sang Lee, Alessio Cortellini

    Հրապարակվել է 2023
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  8. 8
    Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma

    Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma ‌ Petros Fessas, Muntaha Naeem, Matthias Pinter, Thomas U. Marron, David Szafron, Lorenz Balcar, Anwaar Saeed, Tomi Jun, Sirish Dharmapuri, Anuhya Gampa, Yinghong Wang, Uqba Khan, Mahvish Muzaffar, Musharraf Navaid, Pei‐Chang Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Yehia I. Abugabal, Tiziana Pressiani, Nicola Personeni, Naoshi Nishida, Masatoshi Kudo, Ahmed O. Kaseb, Yi‐Hsiang Huang, Celina Ang, Anjana Pillai, Lorenza Rimassa, Abdul Rafeh Naqash, Elad Sharon, Alessio Cortellini, David J. Pinato

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  9. 9
    Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

    Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study ‌ Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Vincent E. Gaillard, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Rohini Sharma, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  10. 10
    Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

    Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma ‌ Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  11. 11
    Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study

    Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study ‌ Thomas Talbot, Antonio D’Alessio, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Sirish Dharmapuri, Celina Ang, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Claudia Angela Maria Fulgenzi, Suneetha Amara, Abdul Rafeh Naqash, Anuhya Gampa, Anjana Pillai, Yinghong Wang, Uqba Khan, Pei‐Chang Lee, Yi‐Hsiang Huang, Bertram Bengsch, Dominik Bettinger, Yehia I. Mohamed, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Masatoshi Kudo, Arndt Weinmann, Peter R. Galle, Ambreen Muhammed, Alessio Cortellini, Arndt Vogel, David J. Pinato

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  12. 12
    Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

    Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma ‌ Mathew Vithayathil, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Y. Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei‐Chang Lee, Yi‐Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma

    Հրապարակվել է 2023
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  13. 13
    The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

    The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma ‌ Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Özbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi‐Hsiang Huang, Dominik Bettinger, Yehia I. Abugabal, Ahmed O. Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco Mauri, Alessio Cortellini, Rohini Sharma, Antonio D’Alessio, Celina Ang, David J. Pinato

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:

Որոնման գործիքներ: